Clinical Trial Update: Use of Canagliflozin in Conjunction With Insulin in a Real-world Setting

View source ↗

Summary

A completed real-world study evaluating the use of canagliflozin in combination with insulin for type 2 diabetes.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 2 Diabetes Mellitus

Drugs mentioned

• INVOKANA (CANAGLIFLOZIN)
• Insulin (insulin)

Snippet

Sponsor: London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's | Conditions: Type 2 Diabetes Mellitus | Status: COMPLETED